Large holder update, amended
Open the filing on sec.gov
Caris Life Sciences, Inc. (CAI)
Nasdaq: CAI · Services-Medical Laboratories · Irving, TX · filing with the SEC since 2024
The companyfiscal 2025, as filed
Revenue$812M+97.0%
Net income-$68.1M+75.8%
Earnings per share$-3.22+69.8%
Operating cash flow$83.2M+133.9%
Cash$796M+1145.2%
Debt$378M+1.4%
Shareholders’ equity$577M+123.1%
Shares, diluted167.2M+371.0%
Return on equity-11.8%
The recordfrom its filings
Filings in 202664
Newest filingNov 5 · SCHEDULE 13G/A
Annual reportMar 3, 2026
Quarterly reportNov 4, 2026
Next report due10-K by Mar 31
Insider sales, 12 months$28.9M
Insider buys, 12 months$1.6M
Patents granted1
Filer categoryNon-accelerated filer<br>Emerging growth company
Trailing twelve months to Sep 2026Revenue $1.05BNet income $96.1MCash from operations $83.9Mthe four newest filed quarters added
Left: the newest annual report, with the change on the year before. Right: counted from the company's own filings with the SEC.
As filed, in USD. Nothing here is a forecast.
The company now
Caris Life Sciences reported second-quarter 2026 revenue of $263.7 million, up from $181.4 million a year earlier 2.
Its testing business, called molecular profiling services, grew 54.8 percent in the quarter on more cases and higher reimbursement, the money insurers pay per test 2.
Clinical cases rose to about 59,200 from about 50,000 2.
The company reported a net loss of $637 thousand in the quarter, against $71.8 million a year earlier 2.
At 30 June 2026 it held cash, cash equivalents, restricted cash and marketable securities of $794.9 million, and owed $400.0 million on a term loan, which is borrowed money repaid on a schedule 2.
As of Oct 28, 2026. Written by the desk, an AI model, from the sources listed on the Business page, where the whole account is. Nothing here is advice.
Newer filings are on file since this was written; an update is queued.
News
Quarterly report
Open the filing on sec.gov
Results released
Open the filing on sec.gov
Insider trade report
Open the filing on sec.gov
Notice of intended sale
Open the filing on sec.gov
Insider trade report
Open the filing on sec.gov
Notice of intended sale
Open the filing on sec.gov
Current report
Open the filing on sec.gov
Insider trade report
Open the filing on sec.gov
Notice of intended sale
Open the filing on sec.gov
Nothing of this kind is on the record for this company yet.
An outside story is shown by its headline, its source and its link only. The SI reads the page when you ask it to break one down.